Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

746 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Completed

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

NCT01158599

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Institut für Spezifische Prophylaxe und Tropenmedizin Vienna, State of Vienna, Austria
  • Medical University of Vienna - Klinische Pharmakologie Vienna, State of Vienna, Austria
  • Universitätsklinikum Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Universitätsklinikum Rostock Rostock, Germany
View Trial Details
Completed

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

NCT00662870

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +27 more
Locations
  • Fayetteville, AR 72703, Arkansas, United States
  • Jonesboro, AR 72401, Arkansas, United States
  • Little Rock, AR 72211, Arkansas, United States
  • Fountain Valley, CA 92708, California, United States
View all 26 locations
View Trial Details
Completed

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

NCT01106482

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Winkelhoferstr. 3 Ehingen, Germany
  • Fuggerplatz 1 Kaufering, Germany
  • Hauptstrasse 240 Kehl, Germany
  • Bismarckstr. 3 Ludwigsburg, Germany
View Trial Details
Completed

Pentavalent DTaP-Hep B-IPV

NCT00133445

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +33 more
Locations
  • UCLA Center For Vaccine Research Torrance, California, United States
View Trial Details

Related conditions